Suppr超能文献

单次剂量美替拉酮试验联合促肾上腺皮质激素和化合物-S刺激作为一种门诊程序来评估下丘脑-垂体-肾上腺功能。

Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.

作者信息

Berneis K, Staub J J, Gessler A, Meier C, Girard J, Müller B

机构信息

Division of Endocrinology, Diabetology and Clinical Nutrition, Department of Internal Medicine, University Hospitals, CH-4031 Basel, Switzerland.

出版信息

J Clin Endocrinol Metab. 2002 Dec;87(12):5470-5. doi: 10.1210/jc.2001-011959.

Abstract

The metyrapone test is used to test the hypothalamic-pituitary-adrenocortical axis. The present study aims to assess the diagnostic accuracy of combined stimulation of ACTH and compound-S (CMP-S). In addition, we analyzed the safety and practicability of this test as an outpatient procedure. A total of 327 metyrapone tests were analyzed retrospectively in 185 patients (mean age, 50.3 +/- 15.2 yr). One hundred thirteen patients had one test, and 72 patients had between 2 and 6 tests over 1-3 yr. Most patients suffered from pituitary adenomas (60 macroadenomas, 63 microadenomas) or other pituitary lesions (n = 29). Metyrapone (2 g) was given at 2400 h as an outpatient procedure. Blood samples for analysis of ACTH, CMP-S, and cortisol were taken at 0730 h. Stimulation of adrenal CMP-S and cortisol by pituitary ACTH demonstrated a dose-response curve with the shape of half a geometric parabola. CMP-S reached a plateau when ACTH rose above 175 ng/liter [r = 0.661, P < 0.0001 for ACTH <175 ng/liter; r = 0.083, P = not significant (NS) for ACTH >175 ng/liter], cortisol flattened at ACTH levels above 230 ng/liter (r = 0.633; P < 0.0001 for ACTH < 230 ng/liter; P = NS for ACTH >230 ng/liter). Alternatively, the sum of CMP-S plus cortisol also flattened when ACTH rose above 230 ng/liter (r = 0.696; P < 0.0001 for ACTH <230; P = NS for ACTH > 230 ng/liter). Receiver operating curve analysis defining a cut-off for ACTH at 150 ng/liter demonstrated a sensitivity of 47% and 67% at a cut-off level for CMP-S at 200 or 260 nmol/liter, respectively. The respective specificity was 82% and 68% for CMP-S. This compared with a sensitivity of 71% and specificity of 69% if the sum of CMP-S plus cortisol of 450 nmol/liter were used as cut-off. The response curve between CMP-S and ACTH implies a maximally stimulated adrenal cortex at circulating ACTH levels above 175 ng/liter. Single measurement of CMP-S using the cut-off at 200 nmol/liter, as suggested in the literature, yields a poor sensitivity of only 47% compared with ACTH. Despite the relatively high cross-reactivity of CMP-S in the cortisol assay, the sum of CMP-S and cortisol levels with a cut-off value of 450 nmol/liter yields a better diagnostic accuracy compared with CMP-S alone.

摘要

甲吡酮试验用于检测下丘脑 - 垂体 - 肾上腺皮质轴。本研究旨在评估促肾上腺皮质激素(ACTH)和化合物S(CMP - S)联合刺激的诊断准确性。此外,我们分析了该试验作为门诊程序的安全性和实用性。回顾性分析了185例患者(平均年龄50.3±15.2岁)的327次甲吡酮试验。113例患者进行了1次试验,72例患者在1 - 3年内进行了2至6次试验。大多数患者患有垂体腺瘤(60例大腺瘤,63例微腺瘤)或其他垂体病变(n = 29)。作为门诊程序,在24:00给予甲吡酮(2g)。于07:30采集血样分析ACTH、CMP - S和皮质醇。垂体ACTH对肾上腺CMP - S和皮质醇的刺激呈现出半条几何抛物线形状的剂量反应曲线。当ACTH升至高于175 ng/升时,CMP - S达到平台期[r = 0.661,ACTH <175 ng/升时P <0.0001;r = 0.083,ACTH >175 ng/升时P =无显著性差异(NS)],当ACTH水平高于230 ng/升时,皮质醇趋于平稳(r = 0.633;ACTH <230 ng/升时P <0.0001;ACTH >230 ng/升时P = NS)。或者,当ACTH升至高于230 ng/升时,CMP - S加皮质醇的总和也趋于平稳(r = 0.696;ACTH <230时P <0.0001;ACTH > 230时P = NS)。将ACTH的临界值定义为150 ng/升的受试者工作特征曲线分析表明,当CMP - S的临界水平分别为200或260 nmol/升时,敏感性分别为47%和67%。CMP - S的相应特异性分别为82%和68%。相比之下,如果将CMP - S加皮质醇的总和450 nmol/升用作临界值,敏感性为71%,特异性为69%。CMP - S与ACTH之间的反应曲线表明,循环ACTH水平高于175 ng/升时肾上腺皮质受到最大刺激。如文献中所建议的,使用200 nmol/升的临界值单次测量CMP - S,与ACTH相比,敏感性仅为47%,较差。尽管CMP - S在皮质醇测定中具有相对较高的交叉反应性,但与单独使用CMP - S相比,临界值为450 nmol/升的CMP - S和皮质醇水平总和具有更好的诊断准确性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验